| Revenue | DKK 43,9M | -85% |
| EBITDA | DKK 8,1M | +8% |
| Net profit | DKK 7M | +12% |
| Total assets | DKK 104,5M | -13% |
| Equity | DKK 51,5M | +16% |
| Employees | 58 | — |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 153.859 | 168.648 | 204.384 | 209.895 | 212.924 | 225.214 | 252.806 | 273.010 | 259.565 | 293.433 | 285.712 | 43.949 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 3.068 | 5.458 | 5.422 | 5.101 | 4.088 | 3.000 | 2.984 | 3.903 | 761 | 6.321 | 7.481 | 8.075 |
| Depreciation & amort. | -0 | -1.758 | -1.510 | -1.570 | -1.900 | -1.167 | -1.262 | -1.347 | -1.133 | -1.089 | -777 | -486 |
| EBIT | 3.068 | 3.700 | 3.912 | 3.531 | 2.188 | 1.833 | 1.722 | 2.556 | -372 | 5.232 | 6.704 | 7.589 |
| Net financials | -561 | 1.495 | -186 | 1.643 | 792 | -798 | 1.298 | 266 | -327 | -937 | 1.251 | 1.387 |
| Profit before tax | 2.507 | 5.195 | 3.726 | 5.173 | 2.980 | 1.036 | 3.020 | 2.823 | -699 | 4.294 | 7.955 | 8.976 |
| Tax | 602 | 1.289 | 851 | 1.114 | 660 | 232 | 665 | 626 | -155 | 948 | 1.755 | 2.024 |
| Net profit | 1.904 | 3.905 | 2.875 | 4.060 | 2.320 | 804 | 2.356 | 2.197 | -544 | 3.346 | 6.200 | 6.951 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 82.538 | 103.145 | 99.419 | 119.521 | 130.008 | 133.968 | 126.429 | 133.792 | 92.014 | 110.006 | 120.293 | 104.540 |
| Equity | 56.983 | 60.889 | 63.763 | 67.823 | 70.143 | 70.947 | 73.303 | 75.500 | 34.956 | 38.302 | 44.502 | 51.453 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 25.030 | 41.726 | 35.204 | 51.321 | 59.602 | 62.811 | 52.985 | 58.251 | 57.059 | 71.704 | 75.791 | 53.087 |
| Total debt | 25.030 | 41.726 | 35.204 | 51.321 | 59.602 | 62.811 | 52.985 | 58.251 | 57.059 | 71.704 | 75.791 | 53.087 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SW Management | Management | 2002 | — | — |
OK Management | Management | 1979 | — | — |
SH Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
MB Management | Management | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 1979 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 1979 | — | — | |
| Board of Directors | 1979 | — | — | |
| Board of Directors | 1979 | — | — | |
| Board of Directors | 1979 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Biofarma Holding A/S | Company | 66.7% | 66.7% | 2021 |
KKA Bilenberg Holding ApS | Company | 10.0% | 10.0% | 2021 |
ENGS Holding ApS | Company | 10.0% | 10.0% | 2021 |
CAND.PHARM. POVL M. ASSENS FOND | Company | 100.0% | 100.0% | 1989 |
| Person | Role here | Other companies |
|---|---|---|
| Søren Wang Petersen | Management | 0 companies |
| Ole Kondrup | Management | 0 companies |
| Søren Hjortebjerg Theil Hansen | Chief Executive Officer | 0 companies |
| Mads Bilenberg | Management | 0 companies |
| Henriette Sidenius | Board of Directors | 0 companies |
| Niels Ulrik | Board of Directors | 0 companies |
| Tyge Jesper Rothe | Chairman | 0 companies |
| Povl Michael Assens | Board of Directors | 0 companies |
| Niels Christian Assens | Board of Directors | 0 companies |
| Allan Philip | Board of Directors | 0 companies |
| Ole Kilsgaard | Board of Directors | 0 companies |